Please assess the completion status of the following clinical trial:

Trial Title: Two Dose Epidural Morphine for Post-cesarean Analgesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women undergoing cesarean section under epidural anesthesia.~Exclusion Criteria:~* Emergent cesarean section~* Coagulopathy~* Failed epidural anesthesia or patchy block~* General anesthesia~* Use of epidural chloroprocaine~* Allergy or contraindication to Non-steroidal anti-inflammatory drug (NSAIDs)~* Severe opioid side effects~* History of chronic opioid use~* History of chronic pain~* History of obstructive sleep apnea~* Morbid obesity (Body Mass Index (BMI)\>45 kg/m2)~* Height under 4' 10 (147 cm)~* Documented dural puncture by the epidural (Tuohy) needle~* Preeclampsia~* Other significant medical disease (American Society of Anesthesiologists (ASA) 3 or more).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Epidural Morphine (Type: ACTIVE_COMPARATOR): Group receiving 3mg epidural morphine, 24 hours after the initial dose
- Epidural Saline (Type: PLACEBO_COMPARATOR): Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.

Based on this trial design, predict the completion outcome and termination type (if applicable).